Result: The ATG start codon was abolished by a point mutation (ntA1814C/T) in three cases; and the ntG1896A mutation introducing a stop signal was present in 10 (27.8%) sequences.
Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia.
Abstract: RESULTS: Among the major mutant variants detected, double BCP mutations (A1762T/G1764A) (25.9%), Kozak sequences mutations (nt1809-1812) (51.7%) and the classical PC mutations such as A1814C/C1816T (15.4%), G1896A (25.2%) and G1862T (44.8%) were predominant mutant variants.
Result: Only mutant variants A1814C/C1816T (23.5 vs. 5.6%) and G1896/C1858T (31.5 vs. 5.6%) were significantly higher in HBeAg negative cases than positives (Fig 2B).
Result: Similarly, the co-prevalence of YMDD
Differential regulation of hepatitis B virus core protein expression and genome replication by a small upstream open reading frame and naturally occurring mutations in the precore region.
Method: The following mutation sites were also detected in the included studies: G1613A, C1653T, 1752G, T1754V, T1753V/A1762T/G1764A, T1758C, G1764A/C1766T/T1768A, T1770A, 1773 T, G1775A, C1799V, T1800C, T1803C, G1809T, A1814C, A1837G, A1846G, T1853C, PMID: 26571502
2015
PloS one
Result: Major substitutions that were detectable in the BCP/PC region of acute isolates included T1753C (2.7%), A1762T/G1764A (8.1%), A1814C (2.7%), G1896A (10.8%) and G1899A (5.4%).
Result: Notably, the frequency of pre-core substitutions (A1814C, G1896A, and G1899A) was relatively high in acute infection reaching to almost half of that present in chronic infection.
Molecular characterization of HBV strains circulating among the treatment-naive HIV/HBV co-infected patients of eastern India.
Result: Six (24%) of the study sequences had preC start codon mutations: three (3321, T033, and N60) had A1814C, two (3354 and 3658) had A1814T, and one (3269) had G1816T.
Discussion: However, preC start codon mutations noted in this study have also been reported in published data from South Africa (A1814C/T, T1815C/A), and in patients from Cameroon who were infected with HBV genotype A3 (A1814C and A1814T).
Discussion: The finding that 24% (6) of the study participants had preC start codon mutations (A1814C/T and G1816T
Variability in the precore and core promoter regions of HBV strains in Morocco: characterization and impact on liver disease progression.
Result: Mutations affecting the initiation of translation of pre-C gene (TIM) were found in 7 (3.8%) patients, including A1814C (three ICs), T1815C (one IC), T1815A (one patient with ACH) and C1817T (two ICs).
[Emergence and clinical significance of YMDD and HBeAg-related mutations during lamivudine treatment].
Abstract: 3 of the 8 patients had G1896A mutant, 2 had A1814C and the remaining had G1896A + A1814C, A1762T and G1764A, A1762T and G1764A + G1896A.
Abstract: METHODS: From sera of chronic hepatitis B patients with 9 - 30 months lamivudine therapy, signal-base mutations of YMDD motif, G1896A, A1814C, A1762T and G1764A were analyzed by gene chips technique.
HBV mutation literature information.
PMID: 
2019
BMC infectious diseases
Browser Board
Co-occurred Entities
Filtrator
ViMRT